1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Flibanserin
Trade Name:
ADDYI
Manufacturer/Distributor:
Sprout Pharmaceuticals Inc.
Imported by Therapeutics Products Inc
Classification:
CNS agent
ATC Class:
G02CX02 - flibanserin
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/02/27
Date Marketed in Canada (yyyy/mm/dd):
2018/02/27
Presentation:
Tablet: 100 mg. DIN: 02473550
Comments:
For the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire for a minimum of 6 months, which occurs 75-100% of the time, that causes marked distress or interpersonal difficulty and is NOT due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.
Source:
Product monograph
Back to:
Drug Product Listings 
